Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeNovaradNovarad’s OpenSight Augmented Reality System Guides the Way in First Surgical Use

Novarad’s OpenSight Augmented Reality System Guides the Way in First Surgical Use

 

Sophisticated app for Microsoft’s HoloLens renders patient studies into 3D and presents them in an interactive manner accurately overlaid directly onto the patient’s body

A patient undergoes an Automated Percutaneous Lumbar Discectomy—or APLD—while Novarad’s OpenSight augmented reality technology assists the operating surgeon, Dr. Wendell Gibby
A patient undergoes an Automated Percutaneous Lumbar Discectomy—or APLD—while Novarad’s OpenSight augmented reality technology assists the operating surgeon, Dr. Wendell Gibby

The OpenSight™ Augmented Reality System guided the way in the first known surgical use of Microsoft’s HoloLens. Novarad Corporation, a leader in the development of medical imaging software, created OpenSight to render patient studies into 3D and present them in an interactive manner accurately overlaid directly onto the patient’s body. This leverages a host of advanced technologies including 3D imaging, advanced segmentation and rendering, registration, motion correction, virtual tools and 3D annotation technologies.

Dr. Wendell Gibby, neuroradiologist and CEO of Novarad, performed the operation. The procedure—Automated Percutaneous Lumbar Discectomy, or APLD—serves to alleviate back and leg pain associated with disk herniation.

“This is very new stuff. It’s the first procedure I’m aware of that has done this in the world. People have performed some work with 3D models and simulations,” Gibby said. “We had some papers recently at the ASNR [American Society of Neuroradiology] about this, but it’s the first time we’ve tried it on a patient.”

The OpenSight software has proven beneficial in overcoming certain obstacles with surgical operations, and has the potential to improve accuracy, increase operational efficiency and to decrease mistakes in surgeries. According to Gibby, it can be difficult to find things surgically and the ability to see three dimensionally eliminates much of the challenge.

Using the HoloLens technology, OpenSight registers medical imaging studies such as MRIs and CTs over the patient in real time, enabling the wearer to both see the patient and see through the patient with dynamic holograms of their internal anatomy.

“We are using cutting-edge augmented reality to display a 3D version of a patient’s anatomy on the actual patient,” said Steve Cvetko, Director of Research and Development at Novarad. “It offers a true, life-size rendering with exact alignment and orientation, which is valuable for medical education, research and, of course, surgery.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

ProSomnus® Sleep Technologies Adds John E. Remmers, MD, to Leadership Team

Dr. John E. Remmers will provide expert medical and strategic guidance on a range of initiatives, including research and development, regulatory clearances, company strategy, medical education, and clinical investigations.

Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of Its Population Health Offering

On August 10th, 2021 Nanox announced that it had entered into an acquisition agreement via merger with Zebra Medical Vision LTD.

Christopher Joyce Joins Miach Orthopaedics as VP & CFO

Christopher Joyce has joined as vice president and chief financial officer, and Kevin Sidow has been appointed to the company’s board of directors.

NGMedical GmbH Receives FDA Clearance for Its AM Titanium Lumbar Interbody BEE® PLIF

The BEE® PLIF cage has been created to benefit from additive manufacturing features. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion.

Recombinant Technologies is Raising Capital to Roll Out a Game Changing Alzheimer’s Treatment

Recombinant Technologies is focused on treating the root cause of Alzheimer's Disease delivering a huge improvement in the quality of life of those afflicted.

Tyber Medical Reaches Agreement to Acquire CatapultMD

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities.

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

By using this website you agree to accept Medical Device News Magazine Privacy Policy